Back
Corcept Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CORT
Corcept Therapeutics, Inc.
Last Price:
$32.35
Seasonality Move:
10.32%
7 Day Trial
ALL ACCESS PASS
$
7
Corcept Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 31.1% based on the past 21 years of stock performance.
-
Corcept Therapeutics, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
-
Is Corcept Therapeutics, Inc. Stock Undervalued?The current Corcept Therapeutics, Inc. [CORT] share price is $33.74. The Score for CORT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 31.1% based on the past 21 years of stock performance.
Corcept Therapeutics, Inc. Stock Rating
Sell
28
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. overpriced?
-
Corcept Therapeutics, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
Corcept Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
117.33
52-Week Low:
28.66
Prediction Charts
Market Cap:
3.6B
Price in USD:
33.74
Volume:
1.2M
Beta:
0.78
Technical Analysis
SMA50:
40.31
SMA100:
59.42
SMA200:
66.54
52-Wk Change:
-39.12%
Stock Predictions
-
Is Corcept Therapeutics, Inc. stock public?Yes, Corcept Therapeutics, Inc. is a publicly traded company.
-
What is the Corcept Therapeutics, Inc. stock quote today?The Corcept Therapeutics, Inc. stock price is 33.74 USD today.
-
How to buy Corcept Therapeutics, Inc. stock online?You can buy Corcept Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-20 | 33.56 | 34.82 | 35.06 | 33.29 |
| Feb-23 | 34.61 | 35.34 | 35.78 | 34.21 |
| Feb-24 | 35.40 | 36.48 | 37.58 | 35.40 |
| Feb-25 | 37.65 | 36.22 | 38.22 | 33.94 |
| Feb-26 | 36.47 | 35.78 | 36.47 | 34.50 |
| Feb-27 | 35.21 | 35.70 | 35.74 | 34.57 |
| Mar-2 | 34.56 | 35.97 | 36.27 | 34.34 |
| Mar-3 | 34.92 | 35.28 | 35.73 | 34.00 |
| Mar-4 | 35.28 | 35.69 | 36.06 | 34.93 |
| Mar-5 | 34.94 | 34.04 | 35.55 | 33.85 |
| Mar-6 | 33.26 | 33.87 | 34.18 | 32.99 |
| Mar-9 | 33.57 | 33.99 | 34.11 | 33.10 |
| Mar-10 | 34.00 | 33.54 | 34.00 | 32.93 |
| Mar-11 | 33.47 | 33.74 | 34.27 | 33.00 |
Corcept Therapeutics, Inc. Earnings
Corcept Therapeutics, Inc. Earnings Report: Per Share Corcept Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics, Inc. Forecast Revenue Growth
Corcept Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.57 per share, and an increase next year of $1.22 per share.
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.